FDA Bioequivalence Standards for NTI Drugs: What You Need to Know
The FDA applies stricter bioequivalence standards for NTI drugs like warfarin, phenytoin, and digoxin to ensure safety. Learn how 90-111% limits, scaled testing, and quality controls protect patients from dangerous dose variations.
- Dec, 10 2025
- 3 Comments